I recognize that every IBD patient is unique and requires an individualized therapy plan. My goal is to educate my patients about their disease and engage them in shared treatment decisions.
I am a gastroenterologist at St. Luke’s University Health Network. I have a special interest in inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis. These are complex conditions that affect many parts of the body and often require life-long therapy and care by several specialists. I practice evidence-based medicine and rely on scientifically proven treatment approaches.
Prior to joining St. Luke’s, I was trained as a physician-scientist and studied the intestinal immune system. Crohn’s disease and ulcerative colitis are complex diseases and we still do not fully understand why they develop and how to best treat them. In recent years, several new medications have become available, and more are being developed, making the management of IBD increasingly more complex. One area of my research focused on understanding why some patients respond only to certain drugs and how to match patient to the “right” medication. Another research interest of mine is cancer immunotherapy which often leads to IBD-like side effects. Lastly, I have done extensive research into norovirus infections, one of the leading causes of gastroenteritis around the world. Moving forward, my goal is to remain engaged in research and use scientific discoveries to improve patient care.
Outside of work, I like to spend time with my wife and three children, travel and undertake home improvement projects that always take longer to complete than anticipated.
“Dr Tomov is an excellent MD”
10/28/2024